The forum is recognized as the leading international stage for those interested in investing and partnering in the biotech and life science industry. Hosted by Sachs Associates this highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect over 650 delegates and over 100 presenting companies.

OBIO Members receive a 10% discount on registration. Mention you are an OBIO Member in the Comments Section

Click HERE to learn more and register!